Trimetazidine Lowers Stroke Risk in Ischemic Heart Disease, Atrial Fibrillation 10/09/25
Welcome to Cardiology Today â Recorded October 09, 2025. This episode summarizes 5 key cardiology studies on topics like ischemic heart disease and secondary mitral regurgitation. Key takeaway: Trimetazidine Lowers Stroke Risk in Ischemic Heart Disease, Atrial Fibrillation.
Article Links:
Article 1: Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population-Based Study (2009-2018). (Journal of the American Heart Association)
Article 2: Blood Pressure Postural Changes Variability Is Associated With Lower Cognition: The S.AGES Cohort. (Journal of the American Heart Association)
Article 3: Multiomics Analysis of Skeletal Muscle Identifies Dysregulation of Hypoxia-Induced Genes in Peripheral Artery Disease. (Journal of the American Heart Association)
Article 4: Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation. (Journal of the American Heart Association)
Article 5: Prognostic Impact of Modified J-MACS Score in Patients With Systolic Heart Failure Receiving Transcatheter Edge-to-Edge Mitral Valve Repair. (Journal of the American Heart Association)
Full episode page: https://podcast.explainheart.com/podcast/trimetazidine-lowers-stroke-risk-in-ischemic-heart-disease-atrial-fibrillation-10-09-25/
đ Featured Articles
Article 1: Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population-Based Study (2009-2018).
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41059636
Summary: This National Health and Nutrition Examination Survey population-based study aimed to assess the prognostic value of the American Heart Association P.R.E.V.E.N.T. Cardiovascular Disease Risk Equations in cancer survivors. Researchers analyzed a nationally representative cohort of U.S. cancer survivors from 2009 to 2018. The study sought to determine the association of baseline cardiovascular risk, as calculated by the P.R.E.V.E.N.T. equations, with all-cause and cardiovascular mortality. Importantly, the provided abstract does not detail the specific findings or conclusions regarding this association or prognostic value.
Article 2: Blood Pressure Postural Changes Variability Is Associated With Lower Cognition: The S.AGES Cohort.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41059541
Summary: This S.A.G.E.S. (Study on Aging, Geriatrics, and the Environment in Solothurn) Cohort study aimed to investigate the specific association between blood pressure postural changes variability and cognitive function in community-dwelling older adults. Building on prior research that linked higher blood pressure variability and postural changes to lower cognitive function, the study sought to clarify this relationship. A previous study notably indicated a greater risk of dementia with higher systolic blood pressure postural changes variability. However, the specific findings and conclusions regarding the association identified in this particular study are not detailed in the provided abstract.
Article 3: Multiomics Analysis of Skeletal Muscle Identifies Dysregulation of Hypoxia-Induced Genes in Peripheral Artery Disease.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41025488
Summary: This cross-sectional multiomics study aimed to investigate the epigenetic regulation of gene expression in peripheral artery disease, focusing on D.N.A. methylation in skeletal muscle. Researchers compared patients with peripheral artery disease, experiencing intermittent claudication or critical limb ischemia, to non-peripheral artery disease controls. The study hypothesizes that epigenetic modifications like D.N.A. methylation play a critical role in hypoxic cell programs relevant to peripheral artery disease. The specific findings regarding dysregulation of hypoxia-induced genes or D.N.A. methylome changes are not elaborated in the provided abstract.
Article 4: Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41025486
Summary: This study found that trimetazidine is associated with an ameliorated stroke risk in patients suffering from both ischemic heart disease and atrial fibrillation. Researchers from Hong Kong analyzed clinical data from 1999 to 2013 to determine if trimetazidine, known to improve myocardial ischemia through glucose oxidation prioritization, clinically reduces stroke risk. The findings suggest that trimetazidine may offer a tangible benefit in reducing stroke incidence in this high-risk population.
Article 5: Prognostic Impact of Modified J-MACS Score in Patients With Systolic Heart Failure Receiving Transcatheter Edge-to-Edge Mitral Valve Repair.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41025485
Summary: This study investigated the prognostic impact of a modified J-M.A.C.S. (Japanese Registry for Mechanically Assisted Circulatory Support) score in patients with systolic heart failure undergoing transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation. Utilizing data from the O.C.E.A.N.-Mitral (Optimized Catheter-based Evaluation and Assessment of Mitral Valve Repair for Functional Mitral Regurgitation) registry, the research aimed to improve risk stratification for these patients. Given the high morbidity and mortality associated with this repair, the development of optimal risk assessment tools like the modified J-M.A.C.S. score is imperative. However, the specific findings detailing the prognostic impact of the modified J-M.A.C.S. score are not provided in the abstract.
đ Transcript
Today’s date is October 09, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population-Based Study (2009-2018). This National Health and Nutrition Examination Survey population-based study aimed to assess the prognostic value of the American Heart Association P.R.E.V.E.N.T. Cardiovascular Disease Risk Equations in cancer survivors. Researchers analyzed a nationally representative cohort of U.S. cancer survivors from 2009 to 2018. The study sought to determine the association of baseline cardiovascular risk, as calculated by the P.R.E.V.E.N.T. equations, with all-cause and cardiovascular mortality. Importantly, the provided abstract does not detail the specific findings or conclusions regarding this association or prognostic value.
Article number two. Blood Pressure Postural Changes Variability Is Associated With Lower Cognition: The S.AGES Cohort. This S.A.G.E.S. (Study on Aging, Geriatrics, and the Environment in Solothurn) Cohort study aimed to investigate the specific association between blood pressure postural changes variability and cognitive function in community-dwelling older adults. Building on prior research that linked higher blood pressure variability and postural changes to lower cognitive function, the study sought to clarify this relationship. A previous study notably indicated a greater risk of dementia with higher systolic blood pressure postural changes variability. However, the specific findings and conclusions regarding the association identified in this particular study are not detailed in the provided abstract.
Article number three. Multiomics Analysis of Skeletal Muscle Identifies Dysregulation of Hypoxia-Induced Genes in Peripheral Artery Disease. This cross-sectional multiomics study aimed to investigate the epigenetic regulation of gene expression in peripheral artery disease, focusing on D.N.A. methylation in skeletal muscle. Researchers compared patients with peripheral artery disease, experiencing intermittent claudication or critical limb ischemia, to non-peripheral artery disease controls. The study hypothesizes that epigenetic modifications like D.N.A. methylation play a critical role in hypoxic cell programs relevant to peripheral artery disease. The specific findings regarding dysregulation of hypoxia-induced genes or D.N.A. methylome changes are not elaborated in the provided abstract.
Article number four. Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation. This study found that trimetazidine is associated with an ameliorated stroke risk in patients suffering from both ischemic heart disease and atrial fibrillation. Researchers from Hong Kong analyzed clinical data from 1999 to 2013 to determine if trimetazidine, known to improve myocardial ischemia through glucose oxidation prioritization, clinically reduces stroke risk. The findings suggest that trimetazidine may offer a tangible benefit in reducing stroke incidence in this high-risk population.
Article number five. Prognostic Impact of Modified J-MACS Score in Patients With Systolic Heart Failure Receiving Transcatheter Edge-to-Edge Mitral Valve Repair. This study investigated the prognostic impact of a modified J-M.A.C.S. (Japanese Registry for Mechanically Assisted Circulatory Support) score in patients with systolic heart failure undergoing transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation. Utilizing data from the O.C.E.A.N.-Mitral (Optimized Catheter-based Evaluation and Assessment of Mitral Valve Repair for Functional Mitral Regurgitation) registry, the research aimed to improve risk stratification for these patients. Given the high morbidity and mortality associated with this repair, the development of optimal risk assessment tools like the modified J-M.A.C.S. score is imperative. However, the specific findings detailing the prognostic impact of the modified J-M.A.C.S. score are not provided in the abstract.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
ischemic heart disease, secondary mitral regurgitation, stroke risk, dementia risk, all-cause mortality, transcatheter mitral valve repair, cognitive function, Peripheral artery disease, skeletal muscle, Cancer survivorship, J-M.A.C.S. score, D.N.A. methylation, Blood pressure variability, National Health and Nutrition Examination Survey, myocardial ischemia, epigenetic regulation, risk stratification, postural changes, P.R.E.V.E.N.T. equations, systolic heart failure, S.A.G.E.S. Cohort, hypoxia-induced genes, cardiovascular risk, Trimetazidine, atrial fibrillation.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow